OTC and dietary supplement labeling compliance under new FDA division.
This article was originally published in The Tan Sheet
Executive Summary
FDA LABELING AND OTC DRUG COMPLIANCE DIVISION ESTABLISHED under the Center for Drug Evaluation and Research's reorganized compliance office, Manufacturing and Product Quality Division Director Douglas Ellsworth reported Oct. 19 at the Nonprescription Drug Manufacturers Association's annual manufacturing seminar in Philadelphia. Formerly part of CDER's Division of Drug Labeling Compliance, which handled all new drug compliance-related issues, the new division has been restructured to deal primarily with OTC drug issues.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning